Platelet-Rich Plasma Injection for Achilles Tendinopathy
Phase-Based Progress Estimates
Effectiveness
Safety
Achilles Tendinopathy+1 More
Platelet-Rich Plasma Injection - ProcedureEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will use real-time ultrasound to study the difference between healthy and unhealthy Achilles tendons, as well as the degree of healing after minimally invasive surgery and injections of Platelet-Rich Plasma.
Eligible Conditions
- Achilles Tendinopathy
Treatment Effectiveness
Effectiveness Progress
Other trials for Achilles Tendinopathy
Study Objectives
3 Primary · 0 Secondary · Reporting Duration: Month 6, Month 9, Month 12
Month 6
Change in tendinopathy assessed by B mode sonographic imaging
Change in tendinopathy assessed by SWE
Month 12
Structure of achilles tendon
Trial Safety
Safety Progress
Other trials for Achilles Tendinopathy
Trial Design
1 Treatment Group
Platelet-Rich Plasma Injection
1 of 1
Experimental Treatment
15 Total Participants · 1 Treatment Group
Primary Treatment: Platelet-Rich Plasma Injection · No Placebo Group · N/A
Platelet-Rich Plasma Injection
Procedure
Experimental Group · 1 Intervention: Platelet-Rich Plasma Injection · Intervention Types: ProcedureTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: month 6, month 9, month 12
Who is running the clinical trial?
Emory UniversityLead Sponsor
1,501 Previous Clinical Trials
2,677,541 Total Patients Enrolled
Felix Gonzalez, MDPrincipal InvestigatorEmory University
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:will be screened for eligibility
Patients with lower extremity pain will be screened for eligibility if they do not have Achilles tendon involvement.
You have a clinical diagnosis of achillodynia.
An ultrasound confirmed the diagnosis of tendinopathy.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments